These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 35452214)
1. Folic Acid-Functionalized Carbon Dot-Enabled Starvation Therapy in Synergism with Paclitaxel against Breast Cancer. Ghosh A; Ghosh AK; Chowdhury M; Das PK ACS Appl Bio Mater; 2022 May; 5(5):2389-2402. PubMed ID: 35452214 [TBL] [Abstract][Full Text] [Related]
2. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite. Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004 [TBL] [Abstract][Full Text] [Related]
3. Manganese-based multifunctional nanoplatform for dual-modal imaging and synergistic therapy of breast cancer. Zhu C; Ma Q; Gong L; Di S; Gong J; Wang Y; Xiao S; Zhang L; Zhang Q; Fu JJ; Lu D; Lin Z Acta Biomater; 2022 Mar; 141():429-439. PubMed ID: 35038584 [TBL] [Abstract][Full Text] [Related]
4. A paclitaxel prodrug with bifunctional folate and albumin binding moieties for both passive and active targeted cancer therapy. Shan L; Zhuo X; Zhang F; Dai Y; Zhu G; Yung BC; Fan W; Zhai K; Jacobson O; Kiesewetter DO; Ma Y; Gao G; Chen X Theranostics; 2018; 8(7):2018-2030. PubMed ID: 29556370 [TBL] [Abstract][Full Text] [Related]
5. Supramolecular self-assembly forming a multifunctional synergistic system for targeted co-delivery of gene and drug. Zhao F; Yin H; Li J Biomaterials; 2014 Jan; 35(3):1050-62. PubMed ID: 24189097 [TBL] [Abstract][Full Text] [Related]
6. In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle. Rezazadeh M; Emami J; Hasanzadeh F; Sadeghi H; Minaiyan M; Mostafavi A; Rostami M; Lavasanifar A Drug Deliv; 2016 Jun; 23(5):1707-17. PubMed ID: 25188785 [TBL] [Abstract][Full Text] [Related]
7. Self-assembled FeS-based cascade bioreactor with enhanced tumor penetration and synergistic treatments to trigger robust cancer immunotherapy. Ren H; Yong J; Yang Q; Yang Z; Liu Z; Xu Y; Wang H; Jiang X; Miao W; Li X Acta Pharm Sin B; 2021 Oct; 11(10):3244-3261. PubMed ID: 34729313 [TBL] [Abstract][Full Text] [Related]
8. Synergistic Anti-Tumor Effect of Toosendanin and Paclitaxel on Triple-Negative Breast Cancer via Regulating ADORA2A-EMT Related Signaling. Zhang J; Xu HX; Wu YL; Cho WCS; Xian YF; Lin ZX Adv Biol (Weinh); 2023 Aug; 7(8):e2300062. PubMed ID: 37401656 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and anti-cancer evaluation of folic acid-peptide- paclitaxel conjugates for addressing drug resistance. Dai Y; Cai X; Bi X; Liu C; Yue N; Zhu Y; Zhou J; Fu M; Huang W; Qian H Eur J Med Chem; 2019 Jun; 171():104-115. PubMed ID: 30913525 [TBL] [Abstract][Full Text] [Related]
10. A paclitaxel and microRNA-124 coloaded stepped cleavable nanosystem against triple negative breast cancer. Chen C; Shen M; Liao H; Guo Q; Fu H; Yu J; Duan Y J Nanobiotechnology; 2021 Feb; 19(1):55. PubMed ID: 33632232 [TBL] [Abstract][Full Text] [Related]
11. Cellular uptake mechanism and comparative evaluation of antineoplastic effects of paclitaxel-cholesterol lipid emulsion on triple-negative and non-triple-negative breast cancer cell lines. Ye J; Xia X; Dong W; Hao H; Meng L; Yang Y; Wang R; Lyu Y; Liu Y Int J Nanomedicine; 2016; 11():4125-40. PubMed ID: 27601899 [TBL] [Abstract][Full Text] [Related]
12. Folic Acid Functionalized Carbon Dot/Polypyrrole Nanoparticles for Specific Bioimaging and Photothermal Therapy. Kim TE; Jang HJ; Park SW; Wei J; Cho S; Park WI; Lee BR; Yang CD; Jung YK ACS Appl Bio Mater; 2021 Apr; 4(4):3453-3461. PubMed ID: 35014429 [TBL] [Abstract][Full Text] [Related]
13. Folate-mediated targeted and intracellular delivery of paclitaxel using a novel deoxycholic acid-O-carboxymethylated chitosan-folic acid micelles. Wang F; Chen Y; Zhang D; Zhang Q; Zheng D; Hao L; Liu Y; Duan C; Jia L; Liu G Int J Nanomedicine; 2012; 7():325-37. PubMed ID: 22287842 [TBL] [Abstract][Full Text] [Related]
14. Metabolic Response of Triple-Negative Breast Cancer to Folate Restriction. Coleman MF; O'Flanagan CH; Pfeil AJ; Chen X; Pearce JB; Sumner S; Krupenko SA; Hursting SD Nutrients; 2021 May; 13(5):. PubMed ID: 34068120 [TBL] [Abstract][Full Text] [Related]
15. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer. He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524 [TBL] [Abstract][Full Text] [Related]
16. Polymeric complex micelles with double drug-loading strategies for folate-mediated paclitaxel delivery. Li M; Liu Y; Feng L; Liu F; Zhang L; Zhang N Colloids Surf B Biointerfaces; 2015 Jul; 131():191-201. PubMed ID: 25988283 [TBL] [Abstract][Full Text] [Related]
17. Novel multi-targeted nanoparticles for targeted co-delivery of nucleic acid and chemotherapeutic agents to breast cancer tissues. Amani A; Alizadeh MR; Yaghoubi H; Nohtani M Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111494. PubMed ID: 33255061 [TBL] [Abstract][Full Text] [Related]
18. Lipoprotein-Inspired Nanocarrier Composed of Folic Acid-Modified Protein and Lipids: Preparation and Evaluation of Tumor-Targeting Effect. Han M; Ji X; Li J; Ge Z; Luo B; Zhou K; Wang Q; Sun X; Zhang W; Li J Int J Nanomedicine; 2020; 15():3433-3445. PubMed ID: 32523342 [TBL] [Abstract][Full Text] [Related]
19. Polyphenol modified CuO nanorods capped by kappa-carrageenan for controlled paclitaxel release in furnishing targeted chemotherapy in breast carcinoma cells. Singh S; Pal K Int J Biol Macromol; 2024 Jan; 255():127893. PubMed ID: 37949284 [TBL] [Abstract][Full Text] [Related]
20. Folic acid based carbon dot functionalized stearic acid-g-polyethyleneimine amphiphilic nanomicelle: Targeted drug delivery and imaging for triple negative breast cancer. Sarkar P; Ghosh S; Sarkar K Colloids Surf B Biointerfaces; 2021 Jan; 197():111382. PubMed ID: 33160259 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]